Galectin-3 and cancer mortality in patients with suspected or known coronary artery disease: the ANOX study
1 September 2024 (11:00 - 11:40)
Organised by: 

About the speaker

NHO Kyoto Medical Centre, Kyoto (Japan)
5 More presentations in this session
Access the full session
The Event
ESC Congress 2024
1 September 2024
11:00 CET
You may be interested in
Congress Session
Congress Session






